Why a Common Asthma Drug Will Now Carry Extra Safety Warnings About Depression
Australia’s Therapeutic Goods Administration recently issued a safety alert requiring extra warnings to be included with the asthma and hay fever drug montelukast.
Tag: montelukast Singulair
Why a Common Asthma Drug Will Now Carry Extra Safety Warnings About Depression
Australia’s Therapeutic Goods Administration recently issued a safety alert requiring extra warnings to be included with the asthma and hay fever drug montelukast.
Read More
Singulair Black Box Warning Did Little to Alert Patients to Potential Side Effects
An article published by the New York Times outlines how an FDA black box warning for the asthma drug Singulair (montelukast) did little to alert patients to its potential mental health side effects or to dissuade physicians from prescribing it.
Read More
Asthma Drug Montelukast Can Block Crucial SARS-CoV-2 Protein
Asthma and allergy drug montelukast (Singulair) can bind to and block a protein produced by the virus SARS-CoV-2 and reduce viral replication.
Read More
FDA Slaps Black Box Warning on Singulair over Serious Mental Health Side Effects
“Because of the risk of mental health side effects, the benefits of montelukast may not outweigh the risks in some patients, particularly when the symptoms of disease may be mild and adequately treated with other medicines,” the FDA said.
Read More